Roivant Sciences Ltd. (ROIV)
USD 9.51
(-5.04%)
USD 9.51
(-5.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 7.22 Billion USD | 202.25% |
| 2023 | 2.38 Billion USD | -7.56% |
| 2022 | 2.58 Billion USD | -0.18% |
| 2021 | 2.58 Billion USD | 4.55% |
| 2020 | 2.47 Billion USD | 78.49% |
| 2019 | 1.38 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.13 Billion USD | -10.05% |
| 2024 Q2 | 2.06 Billion USD | -4.47% |
| 2024 FY | 7.22 Billion USD | 202.25% |
| 2024 Q3 | 7.31 Billion USD | 254.03% |
| 2024 Q4 | 7.22 Billion USD | -1.23% |
| 2023 Q1 | 2.6 Billion USD | 0.59% |
| 2023 Q2 | 2.21 Billion USD | -14.8% |
| 2023 Q4 | 2.38 Billion USD | 8.47% |
| 2023 Q3 | 2.2 Billion USD | -0.57% |
| 2023 FY | 2.38 Billion USD | -7.56% |
| 2022 Q2 | 3.1 Billion USD | 26.41% |
| 2022 FY | 2.58 Billion USD | -0.18% |
| 2022 Q4 | 2.58 Billion USD | -7.65% |
| 2022 Q1 | 2.45 Billion USD | -5.21% |
| 2022 Q3 | 2.79 Billion USD | -9.78% |
| 2021 Q3 | 2.59 Billion USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q4 | 2.58 Billion USD | -0.16% |
| 2021 FY | 2.58 Billion USD | 4.55% |
| 2020 Q4 | 2.47 Billion USD | 0.0% |
| 2020 FY | 2.47 Billion USD | 78.49% |
| 2019 FY | 1.38 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -385.351% |
| Alkermes plc | 2.13 Billion USD | -238.096% |
| Agenus Inc. | 313.91 Million USD | -2200.791% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -88.582% |
| Aptorum Group Limited | 20.64 Million USD | -34892.491% |
| Ardelyx, Inc. | 297.57 Million USD | -2327.081% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -843.435% |
| Bicycle Therapeutics plc | 595.34 Million USD | -1113.161% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -9699.574% |
| ChromaDex Corporation | 54.96 Million USD | -13040.386% |
| Chimerix, Inc. | 212.77 Million USD | -3294.438% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -25446.058% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -1537.87% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -223.94% |
| Precision BioSciences, Inc. | 159.78 Million USD | -4420.238% |
| Dyadic International, Inc. | 8.21 Million USD | -87772.912% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -22655.142% |
| Fortress Biotech, Inc. | 167.52 Million USD | -4211.26% |
| Lantern Pharma Inc. | 43.64 Million USD | -16447.254% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -4376.643% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -49687.397% |
| Incyte Corporation | 6.78 Billion USD | -6.493% |
| IO Biotech, Inc. | 150.71 Million USD | -4692.05% |
| Jaguar Health, Inc. | 50.76 Million USD | -14127.847% |
| Novavax, Inc. | 1.85 Billion USD | -289.28% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -1798.62% |
| Opthea Limited | 188.79 Million USD | -3725.645% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -766.978% |
| ContextLogic Inc. | 423 Million USD | -1607.443% |
| MiMedx Group, Inc. | 239.04 Million USD | -2921.365% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -4057.398% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -139607.925% |
| NextCure, Inc. | 129.41 Million USD | -5480.74% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -13287.859% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -19564.249% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -22259.933% |
| Vaxcyte, Inc. | 1.4 Billion USD | -412.991% |
| PDS Biotechnology Corporation | 59.39 Million USD | -12061.092% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -1027.549% |
| Pharming Group N.V. | 462.85 Million USD | -1460.423% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -18572.394% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -1049.061% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -38066.382% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -38066.382% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -4268.789% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -15848.246% |
| Acelyrin, Inc. | 742.69 Million USD | -872.476% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -109555.459% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -112698.407% |
| Summit Therapeutics Inc. | 202.94 Million USD | -3458.767% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -9611.031% |
| Senti Biosciences, Inc. | 119.48 Million USD | -5944.727% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -3063.011% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -4194.648% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -87307.503% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -151195.203% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -1439.345% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -5740.927% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -2526.844% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -1427.468% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -71374.339% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -3267.03% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -637838.841% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -1645.227% |
| Immix Biopharma, Inc. | 19.92 Million USD | -36148.05% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -1851.89% |
| MEI Pharma, Inc. | 41.37 Million USD | -17356.15% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -22187.484% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -2019.285% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -6061.213% |
| Fortress Biotech, Inc. | 167.52 Million USD | -4211.26% |
| Precigen, Inc. | 151.04 Million USD | -4681.739% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -21131.354% |
| AlloVir, Inc. | 190.79 Million USD | -3685.447% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -1818.572% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -1326.756% |
| ImmuCell Corporation | 43.8 Million USD | -16386.635% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -1012.322% |
| Onconetix, Inc. | 88.82 Million USD | -8031.462% |
| PureTech Health plc | 693.97 Million USD | -940.744% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -7293.645% |
| Elevation Oncology, Inc. | 89.09 Million USD | -8006.859% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -116354.079% |
| Seer, Inc. | 436.26 Million USD | -1555.511% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -8751.406% |
| Innoviva, Inc. | 1.24 Billion USD | -480.816% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -5354.099% |
| ESSA Pharma Inc. | 149.12 Million USD | -4743.333% |
| GlycoMimetics, Inc. | 45.31 Million USD | -15837.872% |
| GT Biopharma, Inc. | 14.1 Million USD | -51090.602% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -2245.777% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -2888.164% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -1430.488% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -14146.37% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -7485.685% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -1143443.259% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -1175.289% |
| Aptose Biosciences Inc. | 12.92 Million USD | -55790.558% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -32559.805% |
| Soligenix, Inc. | 9.79 Million USD | -73618.911% |
| Century Therapeutics, Inc. | 360.69 Million USD | -1902.402% |
| Kura Oncology, Inc. | 448.93 Million USD | -1508.804% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -2553.87% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -41660.52% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -6411.943% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -3420.569% |
| Autolus Therapeutics plc | 375.38 Million USD | -1824.04% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -2770.21% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -1933.448% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -14600.159% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -992.438% |
| GRI Bio, Inc. | 2.95 Million USD | -244232.95% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -68003.047% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -4135.687% |
| IGM Biosciences, Inc. | 423.41 Million USD | -1605.785% |
| INmune Bio, Inc. | 57 Million USD | -12570.799% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -3145.972% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -8504.21% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -27554.483% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -104829.208% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -9501.045% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -4804.645% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -4263.932% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -1047.147% |
| Verastem, Inc. | 149.71 Million USD | -4724.057% |
| Abeona Therapeutics Inc. | 64 Million USD | -11184.775% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -1310.217% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -4576.047% |
| Histogen Inc. | 19.07 Million USD | -37767.572% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -31787.093% |
| Surrozen, Inc. | 46.08 Million USD | -15573.789% |
| Organovo Holdings, Inc. | 6.34 Million USD | -113657.789% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -167528.661% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -4914.68% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -61097.102% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -9495.687% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -84678.378% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -1889.834% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -39815.572% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -1581.986% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -57168.017% |
| Apollomics, Inc. | 55.38 Million USD | -12940.031% |
| Amarin Corporation plc | 831.68 Million USD | -768.417% |
| Mesoblast Limited | 669.15 Million USD | -979.347% |
| Turnstone Biologics Corp. | 112.81 Million USD | -6302.058% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -1154.428% |
| Synaptogenix, Inc. | 31.11 Million USD | -23113.214% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -59178.414% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -1217.822% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -122893.205% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -98229.825% |
| Exelixis, Inc. | 2.94 Billion USD | -145.466% |
| Better Therapeutics, Inc. | 22.94 Million USD | -31380.112% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -1881.265% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -815.71% |
| NLS Pharmaceutics AG | 1.84 Million USD | -391014.57% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -90422.789% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -49049.248% |
| Gritstone bio, Inc. | 177.76 Million USD | -3962.847% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -7472.323% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -40334.29% |
| Avid Bioservices, Inc. | 336.55 Million USD | -2045.991% |
| Insmed Incorporated | 1.32 Billion USD | -443.11% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -74912.705% |
| MediWound Ltd. | 66.45 Million USD | -10767.575% |
| OmniAb, Inc. | 401.98 Million USD | -1696.704% |
| Alector, Inc. | 621.82 Million USD | -1061.494% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -1914.078% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -134196.802% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -12639.861% |
| Zai Lab Limited | 1.03 Billion USD | -596.952% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -1409.546% |
| Aura Biosciences, Inc. | 255.07 Million USD | -2731.513% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -862.96% |
| Immunic, Inc. | 54.29 Million USD | -13201.317% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -2612.934% |
| Veracyte, Inc. | 1.13 Billion USD | -534.764% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -60989.53% |
| FibroGen, Inc. | 423.52 Million USD | -1605.31% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -205492.997% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -152382.253% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -132923.506% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 36.608% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -81927.053% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -1295.773% |
| TG Therapeutics, Inc. | 329.58 Million USD | -2091.373% |
| Galecto, Inc. | 38.22 Million USD | -18793.667% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -25086.504% |
| Fortrea Holdings Inc. | 4.35 Billion USD | -65.76% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -2968.122% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -28973.674% |
| XBiotech Inc. | 227.24 Million USD | -3078.308% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -7472.323% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -4964.854% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -2426.085% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -5548.345% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -1790.707% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -384.401% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -1879.619% |
| Vaxxinity, Inc. | 44.35 Million USD | -16184.089% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -1297.107% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -38711.078% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -2267.639% |
| NexImmune, Inc. | 8.59 Million USD | -83941.481% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -67304.143% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -42069.19% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 78.167% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -32505.477% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -1841125.192% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -4066.921% |
| Ainos, Inc. | 31.84 Million USD | -22582.389% |
| Pluri Inc. | 39.52 Million USD | -18172.275% |
| Prothena Corporation plc | 696.38 Million USD | -937.144% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -2455.581% |
| Celularity Inc. | 143.88 Million USD | -4919.482% |
| Rallybio Corporation | 115.62 Million USD | -6146.741% |
| Cue Biopharma, Inc. | 61.53 Million USD | -11638.147% |
| MeiraGTx Holdings plc | 458.16 Million USD | -1476.383% |
| Omeros Corporation | 378.26 Million USD | -1809.351% |
| Humacyte, Inc. | 128.22 Million USD | -5532.751% |
| Immunocore Holdings plc | 597 Million USD | -1109.794% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -23005.288% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -10439.154% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -588.347% |
| CalciMedica, Inc. | 12.18 Million USD | -59173.549% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -2747.42% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -4125.947% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -2222.08% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -1177.639% |
| Pulmatrix, Inc. | 33.95 Million USD | -21168.867% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -26506.064% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -5027.492% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -455.158% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -5447.689% |
| Cytokinetics, Incorporated | 824.31 Million USD | -776.179% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -34092.501% |
| Nutriband Inc. | 7.51 Million USD | -95980.006% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -9047.709% |
| Vor Biopharma Inc. | 209.82 Million USD | -3342.096% |
| Evogene Ltd. | 51.1 Million USD | -14033.739% |
| ProKidney Corp. | 420.55 Million USD | -1617.381% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -13071.78% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -75764.192% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -1221.879% |
| CorMedix Inc. | 82.05 Million USD | -8701.469% |
| BioLineRx Ltd. | 63.92 Million USD | -11198.368% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -1694.107% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -25511.638% |
| Atai Life Sciences N.V. | 293.47 Million USD | -2360.996% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -4327.454% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -5568.337% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -1185.077% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -7367.49% |
| MediciNova, Inc. | 66.26 Million USD | -10798.573% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -8112.219% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -161753.233% |
| GeoVax Labs, Inc. | 9.28 Million USD | -77701.482% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -1127.82% |
| Biomea Fusion, Inc. | 199.92 Million USD | -3512.56% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -279.495% |
| Mereo BioPharma Group plc | 66.49 Million USD | -10761.039% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -1388.877% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -1078.45% |
| Absci Corporation | 234.48 Million USD | -2980.212% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -98635.229% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -2024.941% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -4275.088% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -1272.255% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -2500.887% |
| Allakos Inc. | 243.61 Million USD | -2864.772% |
| Imunon, Inc. | 21.91 Million USD | -32852.182% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -2702.736% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -1062.073% |
| BioAtla, Inc. | 119.65 Million USD | -5935.937% |
| NLS Pharmaceutics AG | 1.84 Million USD | -391014.57% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -224200.683% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -1023.532% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -7428.516% |
| XOMA Corporation | 234.3 Million USD | -2982.566% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -3164.62% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -5639.234% |
| aTyr Pharma, Inc. | 122.06 Million USD | -5816.818% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -4592.879% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -1144.674% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -1372.702% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -6438.017% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -47549.374% |
| Akari Therapeutics, Plc | 4.35 Million USD | -165743.444% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -42292.093% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -316.697% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -234093.086% |
| UroGen Pharma Ltd. | 178.31 Million USD | -3950.497% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -1434.296% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -1299573.754% |
| Orgenesis Inc. | 14.55 Million USD | -49532.229% |
| Entera Bio Ltd. | 11.76 Million USD | -61289.562% |
| GH Research PLC | 226.3 Million USD | -3091.552% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -13105.255% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -6622.59% |
| Xencor, Inc. | 952.69 Million USD | -658.113% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -92688.984% |
| Replimune Group, Inc. | 487.72 Million USD | -1380.86% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -89385.843% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -1013.824% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -234093.086% |
| Portage Biotech Inc. | 7.77 Million USD | -92745.893% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -161753.233% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -2507.912% |
| OncoCyte Corporation | 74.89 Million USD | -9543.863% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -355118.94% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -124712.987% |
| Purple Biotech Ltd. | 44.3 Million USD | -16202.835% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -21064.162% |
| scPharmaceuticals Inc. | 94.47 Million USD | -7544.537% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -39924.931% |
| HilleVax, Inc. | 344.43 Million USD | -1996.913% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -227308.123% |
| Tharimmune, Inc. | 10.94 Million USD | -65880.474% |
| Genprex, Inc. | 10.67 Million USD | -67585.86% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -1355.573% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -7403.721% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -297611.542% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -173290.573% |
| OKYO Pharma Limited | 1.54 Million USD | -468507.714% |
| Savara Inc. | 177.56 Million USD | -3967.537% |
| Curis, Inc. | 77.28 Million USD | -9245.62% |
| Daré Bioscience, Inc. | 21.28 Million USD | -33836.703% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -11194.163% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -89220.826% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -37185.024% |
| BeiGene, Ltd. | 5.8 Billion USD | -24.412% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -59251.483% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -245.806% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -1917.729% |
| Erasca, Inc. | 395.29 Million USD | -1727.103% |
| bluebird bio, Inc. | 619.16 Million USD | -1066.495% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -166956.802% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | -5.567% |
| DBV Technologies S.A. | 182.98 Million USD | -3847.013% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -166956.802% |
| Moderna, Inc. | 18.42 Billion USD | 60.803% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -39546.934% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -62238.011% |
| Molecular Templates, Inc. | 35.38 Million USD | -20312.294% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -5123.652% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -815.498% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -2277.733% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -6848.302% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -1451.13% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -2204.285% |
| MacroGenics, Inc. | 306.82 Million USD | -2253.98% |
| RenovoRx, Inc. | 1.46 Million USD | -492565.894% |
| Adicet Bio, Inc. | 207.29 Million USD | -3384.156% |
| Prime Medicine, Inc. | 193.85 Million USD | -3625.79% |
| Aditxt, Inc. | 44.57 Million USD | -16101.779% |
| Adagene Inc. | 115.72 Million USD | -6140.866% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -162050.326% |
| Quantum-Si incorporated | 298.25 Million USD | -2321.62% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -385.561% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -93587.466% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -1956.041% |
| SciSparc Ltd. | 11.18 Million USD | -64490.252% |
| Vericel Corporation | 353.65 Million USD | -1942.228% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -59039.55% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -12593.153% |
| Generation Bio Co. | 374.75 Million USD | -1827.239% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -2736.061% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -4454.846% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -2015.765% |
| Invivyd, Inc. | 229.18 Million USD | -3051.431% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -755.765% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -59250.015% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -3859.911% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -35262.72% |
| 2seventy bio, Inc. | 565.42 Million USD | -1177.352% |
| ADMA Biologics, Inc. | 329.18 Million USD | -2094.07% |
| Clene Inc. | 52.34 Million USD | -13698.9% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -12196.867% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -5460.289% |
| GeoVax Labs, Inc. | 9.28 Million USD | -77701.482% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -1004.864% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -6870.757% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -5439.308% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -7303.722% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -10072.94% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -2877.692% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -268.477% |
| Evaxion Biotech A/S | 12.88 Million USD | -55937.672% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -2765.382% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -859.559% |
| Trevena, Inc. | 40.6 Million USD | -17687.174% |
| Surrozen, Inc. | 46.08 Million USD | -15573.789% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -3097.812% |
| Cingulate Inc. | 3.49 Million USD | -206762.792% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -43333.051% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -10894.797% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -61711.832% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -2589.767% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -864.34% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -5637.046% |
| Clearmind Medicine Inc. | 4.32 Million USD | -166917.398% |
| Kronos Bio, Inc. | 213.27 Million USD | -3286.401% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -4420.153% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -84268.777% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -1860.021% |
| Statera Biopharma, Inc. | 21.16 Million USD | -34017.097% |
| ImmunityBio, Inc. | 504.45 Million USD | -1331.748% |
| Korro Bio, Inc. | 221.66 Million USD | -3158.316% |
| Kineta, Inc. | 10.28 Million USD | -70150.773% |
| BioVie Inc. | 25.2 Million USD | -28551.155% |
| Codexis, Inc. | 136.56 Million USD | -5188.832% |
| Celularity Inc. | 143.88 Million USD | -4919.482% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -1036.767% |
| Celcuity Inc. | 191.21 Million USD | -3677.066% |
| Virax Biolabs Group Limited | 5.48 Million USD | -131601.729% |
| Cibus, Inc. | 544.41 Million USD | -1226.66% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -5636.955% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -35056.162% |
| IN8bio, Inc. | 33.7 Million USD | -21325.975% |
| Kodiak Sciences Inc. | 479.37 Million USD | -1406.655% |
| Annexon, Inc. | 297.67 Million USD | -2326.306% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -4074.604% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -5153.899% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -34304.24% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -141.549% |
| Eyenovia, Inc. | 28.77 Million USD | -24996.036% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -3033.017% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -99878.987% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -11754.515% |
| Arcellx, Inc. | 825.13 Million USD | -775.312% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -8747.069% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -1462.378% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -23387.746% |
| Moolec Science SA | 24.05 Million USD | -29929.501% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -2228.894% |
| Geron Corporation | 394.07 Million USD | -1732.764% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -7001.054% |
| Royalty Pharma plc | 16.38 Billion USD | 55.912% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -1113.928% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -103154.797% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -59950.655% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -3094.94% |
| Humacyte, Inc. | 128.22 Million USD | -5532.751% |
| Structure Therapeutics Inc. | 482.01 Million USD | -1398.387% |
| 89bio, Inc. | 596.26 Million USD | -1111.279% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -2764.337% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -390304.432% |
| Genelux Corporation | 27.89 Million USD | -25793.529% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -7978.568% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -3048.025% |
| Notable Labs, Ltd. | 19.54 Million USD | -36860.657% |
| Liquidia Corporation | 120.43 Million USD | -5897.195% |
| Mustang Bio, Inc. | 17.74 Million USD | -40608.387% |
| Immunovant, Inc. | 666.71 Million USD | -983.299% |
| Quantum-Si incorporated | 298.25 Million USD | -2321.62% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -4901.684% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -13235.454% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -4014.296% |
| Acasti Pharma Inc. | 73.3 Million USD | -9753.318% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -158556.331% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -27554.483% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -648.6% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -139063.702% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -31603.973% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -13896.244% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -3897.145% |
| PepGen Inc. | 143.05 Million USD | -4948.851% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -18798.611% |
| United Therapeutics Corporation | 7.16 Billion USD | -0.774% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -37546.505% |
| Solid Biosciences Inc. | 164.93 Million USD | -4278.881% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -122893.205% |
| Immuneering Corporation | 102.58 Million USD | -6940.517% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -167528.661% |
| Silo Pharma, Inc. | 7.74 Million USD | -93139.744% |
| Belite Bio, Inc | 94.64 Million USD | -7531.371% |
| XOMA Corporation | 234.3 Million USD | -2982.566% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -2997.279% |
| Bionomics Limited | 27.64 Million USD | -26021.949% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -1699.305% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -6625.595% |
| uniQure N.V. | 831.68 Million USD | -768.411% |
| Cassava Sciences, Inc. | 151.66 Million USD | -4662.191% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -162050.326% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -2537.049% |
| Forte Biosciences, Inc. | 38.98 Million USD | -18428.687% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -177220.89% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -19509.791% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -99878.987% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -205492.997% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -60998.74% |
| Altimmune, Inc. | 210.64 Million USD | -3328.827% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -828.483% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -6625.595% |
| Compugen Ltd. | 121.33 Million USD | -5852.562% |
| Peak Bio, Inc. | 2.59 Million USD | -278071.325% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -4091.149% |
| Benitec Biopharma Inc. | 52.21 Million USD | -13733.522% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -2012.708% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -20670.374% |
| Zura Bio Limited | 100.84 Million USD | -7062.105% |
| PolyPid Ltd. | 15.37 Million USD | -46884.66% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -5954.761% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -20670.374% |
| Instil Bio, Inc. | 325.63 Million USD | -2118.003% |
| argenx SE | 4.54 Billion USD | -58.999% |
| Immunome, Inc. | 148.54 Million USD | -4762.315% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -4503.973% |
| Verona Pharma plc | 308.12 Million USD | -2244.018% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -8205.618% |
| Shattuck Labs, Inc. | 159.56 Million USD | -4426.386% |
| CervoMed Inc. | 9.97 Million USD | -72323.833% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -3732.45% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -63321.865% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -3925.797% |
| Moolec Science SA | 24.05 Million USD | -29929.501% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -117963.026% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -4076.187% |
| AnaptysBio, Inc. | 452.38 Million USD | -1496.52% |
| Design Therapeutics, Inc. | 289.64 Million USD | -2393.581% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -9817.586% |
| NeurAxis, Inc. | 509.49 Thousand USD | -1417468.273% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -133205.316% |
| Lumos Pharma, Inc. | 40.63 Million USD | -17672.73% |
| Achilles Therapeutics plc | 161.45 Million USD | -4373.344% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -8205.618% |
| 180 Life Sciences Corp. | 5.25 Million USD | -137223.224% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -10155.158% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -84268.777% |
| Nutriband Inc. | 7.51 Million USD | -95980.006% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -2735.838% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -3523.907% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -9376.83% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -12370.616% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -1271.687% |
| Palisade Bio, Inc. | 14.05 Million USD | -51298.249% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -3334.453% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -394.787% |
| Neurogene Inc. | 222.57 Million USD | -3144.995% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -1016.958% |
| AEON Biopharma, Inc. | 6.84 Million USD | -105414.711% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -1494.24% |
| Sesen Bio, Inc. | 189.17 Million USD | -3717.904% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -2556.623% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -52573.209% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -825.543% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -2605.11% |
| Athira Pharma, Inc. | 160.24 Million USD | -4407.15% |
| Vaccinex, Inc. | 3.63 Million USD | -198811.65% |
| HCW Biologics Inc. | 28.51 Million USD | -25229.902% |
| XOMA Corporation | 234.3 Million USD | -2982.566% |
| Nektar Therapeutics | 398.03 Million USD | -1714.544% |
| Arvinas, Inc. | 1.3 Billion USD | -453.617% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -42292.093% |
| Merus N.V. | 458.49 Million USD | -1475.262% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -3434.092% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -3907.948% |
| Rezolute, Inc. | 132.73 Million USD | -5341.197% |
| Clene Inc. | 52.34 Million USD | -13698.9% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -48295.477% |
| BeyondSpring Inc. | 24.8 Million USD | -29013.52% |
| Synlogic, Inc. | 75.55 Million USD | -9459.87% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -60787.557% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -77030.308% |
| Peak Bio, Inc. | 2.59 Million USD | -278071.325% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -4031.075% |
| Krystal Biotech, Inc. | 818.35 Million USD | -782.561% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -2903.885% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -895.123% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -201804.688% |
| MannKind Corporation | 475.19 Million USD | -1419.889% |
| Ikena Oncology, Inc. | 192.09 Million USD | -3659.908% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -53903.903% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -6097.481% |
| Gossamer Bio, Inc. | 311.91 Million USD | -2215.521% |
| CohBar, Inc. | 16.36 Million USD | -44031.913% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -20440.005% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -98635.229% |
| Legend Biotech Corporation | 1.84 Billion USD | -290.698% |
| Mural Oncology plc | 301.74 Million USD | -2293.571% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -23037.857% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -127047.307% |
| Disc Medicine, Inc. | 367.99 Million USD | -1862.652% |
| Champions Oncology, Inc. | 26.13 Million USD | -27538.459% |
| REGENXBIO Inc. | 573.97 Million USD | -1158.338% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -266600.713% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -4578.198% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -59710.643% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -2024.041% |
| Vaxart, Inc. | 91.83 Million USD | -7765.057% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -11956.784% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -4769.3% |
| Cellectis S.A. | 334.27 Million USD | -2060.673% |
| Longeveron Inc. | 12.17 Million USD | -59207.62% |
| Repare Therapeutics Inc. | 253.9 Million USD | -2744.606% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -121.238% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -3496.012% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -245.806% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -444360.431% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -2500.719% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -4328.308% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -5105.618% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -28199.044% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 68.225% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -525.91% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -59039.55% |
| Veru Inc. | 50.59 Million USD | -14174.829% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -15755.118% |
| Cingulate Inc. | 3.49 Million USD | -206762.792% |
| Passage Bio, Inc. | 150.54 Million USD | -4697.557% |
| Context Therapeutics Inc. | 16.06 Million USD | -44864.211% |
| Exicure, Inc. | 11.58 Million USD | -62270.311% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -1820.628% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -4368.196% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -41237.466% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -2070.576% |
| Nuvalent, Inc. | 732.38 Million USD | -886.161% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -48230.058% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -7964.946% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -50794.807% |
| OmniAb, Inc. | 401.98 Million USD | -1696.704% |
| Anew Medical, Inc. | 19.45 Million USD | -37022.222% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -26923.618% |
| Lipocine Inc. | 23 Million USD | -31300.632% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -5066.037% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -2263.648% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -8504.21% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -5842.473% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -90920.567% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -718.618% |
| Ocugen, Inc. | 64.54 Million USD | -11089.493% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -5699.281% |
| Q32 Bio Inc. | 306.11 Million USD | -2259.371% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -171536.93% |
| Alumis Inc. Common Stock | 89.61 Million USD | -7959.726% |
| Equillium, Inc. | 50.53 Million USD | -14193.453% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -9505.003% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -17399.068% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -424538.814% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -27528.943% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -11107.899% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -193682.212% |
| Dominari Holdings Inc. | 57.55 Million USD | -12448.181% |
| Edesa Biotech, Inc. | 8.89 Million USD | -81138.774% |
| vTv Therapeutics Inc. | 11.01 Million USD | -65451.661% |
| Bio-Techne Corporation | 2.81 Billion USD | -156.736% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -670.712% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -790.073% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -2501.15% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -17219.27% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -981.877% |
| Nkarta, Inc. | 378.88 Million USD | -1806.246% |
| BioCardia, Inc. | 2.98 Million USD | -241697.188% |
| Iterum Therapeutics plc | 26.25 Million USD | -27404.787% |